Insider Trading & Ownership of Michael W. Kalb

Location
Dix Hills, NY
Summary
The estimated net worth of Michael W. Kalb is at least $2,594,167 dollars as of 06 Jan 2026. Michael W. Kalb is the Executive Vice President & CFO of CATALYST PHARMACEUTICALS, INC. and owns shares of CATALYST PHARMACEUTICALS, INC. (CPRX) stock worth about $2.23M. Michael W. Kalb is the SVP and CFO of AMARIN CORP PLC\UK and owns shares of AMARIN CORP PLC\UK (AMRN) stock worth about $367.7K.
Signature
/s/ Michael W. Kalb
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Michael W. Kalb and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Michael W. Kalb has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,594,167.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: CATALYST PHARMACEUTICALS, INC. ($2,226,495).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Michael W. Kalb

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CPRX CATALYST PHARMACEUTICALS, INC. Executive Vice President & CFO $2,226,495 05 Jan 2026
AMRN AMARIN CORP PLC\UK SVP and CFO $367,672 29 Jul 2022
CINC CinCor Pharma, Inc. EVP & Chief Financial Officer 24 Feb 2023
IMPL IMPEL PHARMACEUTICALS INC Cfo 10 May 2023

Insider Transactions Reported by Michael W. Kalb:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .